vTv Therapeutics (VTVT) Change in Receivables (2014 - 2024)
vTv Therapeutics (VTVT) reported Change in Receivables of -$180000.0 for Q4 2024, down 276.47% on a YoY basis from $102000.0 in Q1 2024, and down 181.25% sequentially from -$64000.0 in Q3 2024.
vTv Therapeutics (VTVT) Change in Receivables (2014 - 2024) Analysis & Trends
vTv Therapeutics (VTVT) has 10 years of Change in Receivables data on file, last reported at -$180000.0 in Q4 2024.
- For the quarter ending Q4 2024, Change in Receivables fell 276.47% year-over-year to -$180000.0; the trailing twelve-month figure through Dec 2024 stood at -$40000.0 (up 43.66% YoY), and the FY2024 full-year result was -$40000.0, up 43.66% from the prior year.
- Change in Receivables eased to -$180000.0 in Q4 2024, from -$64000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $928000.0 in Q3 2021 to a low of -$871000.0 in Q4 2021.
- A 5-year average of $4133.3 and a median of -$2000.0 in 2021 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 6528.57% in 2021, while the deepest fall reached 704.86% in 2021.
- Tracing VTVT's Change in Receivables over 5 years: stood at $144000.0 in 2020, then sank by 704.86% to -$871000.0 in 2021, then surged by 113.32% to $116000.0 in 2022, then retreated by 12.07% to $102000.0 in 2023, then plunged by 276.47% to -$180000.0 in 2024.
- Business Quant data shows VTVT's Change in Receivables at -$180000.0 in Q4 2024, -$64000.0 in Q3 2024, and -$675000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -180,000.00 |
| Dec 31, 2024 | -180,000.00 |
| Sep 30, 2024 | -64,000.00 |
| Sep 30, 2024 | -64,000.00 |
| Jun 30, 2024 | -675,000.00 |
| Jun 30, 2024 | -675,000.00 |
| Mar 31, 2024 | 879,000.00 |
| Mar 31, 2024 | 879,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Mar 31, 2023 | -173,000.00 |
| Mar 31, 2023 | -173,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | -20,000.00 |
| Sep 30, 2022 | -20,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Dec 31, 2021 | -871,000.00 |
| Dec 31, 2021 | -871,000.00 |